Avantor, Inc.
NYSE:AVTRMedical - Instruments & Supplies
+$0.07 today
- Market cap
- $10.41B
- Beta
- 0.96
- P/E (TTM)
- -11.7
- EPS (TTM)
- -$0.81
Volume 5.94M
Average 9.44M
AVTR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Avantor, Inc.NYSE: AVTR
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA declines year over year
Q2 FY2026 EBITDA of $226.2M fell 0.7% year over year, ahead of the -91.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at -55.0% a year.
Context
- EBITDA amounted to 2.1% of revenue in FY2025, down 19.7 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 11 analysts of $1.24B (+795.4%) for the fiscal year ending Dec 2026, a step up from the -90.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $226.2M+4.8% QoQ
- Last fiscal yearDec 2025
- $138.7M-90.6% YoY
- LTMJun 2026
- $125.3M-91.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.7% | +158.3% | +159.0 pp |
| 1 year | -90.6% | +795.4% | +886.1 pp |
| 3-year CAGR | -55.0% | +109.9% | +164.9 pp |
| 5-year CAGR | +57.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 138.7M USD
- Year-over-year change
- -90.6%
- 4-year CAGR
- -43.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 138.7M | -90.6% |
| FY2024 | 2024-12-31 | 1.48B | +34.7% |
| FY2023 | 2023-12-31 | 1.1B | -27.9% |
| FY2022 | 2022-12-31 | 1.52B | +12.8% |
| FY2021 | 2021-12-31 | 1.35B | — |
EBITDA vs competitors
How AVTR compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -91.1% is the 7th highest of 9, against a peer median of -13.6%.
- EBITDA amounts to 1.9% of revenue for AVTR, versus a peer median of 21.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $7.09B USD | +3.2% | -9.9% | 27.7% | |
| LTM Jun 2026 | $870.4M USD | +14.5% | -1.6% | 26.2% | |
| LTM Jun 2026 | $514.7M USD | -22.7% | — | 19.9% | |
| LTM Jun 2026 | €296.36M EUR | -4.5% | +4.4% | 24.3% | |
| LTM Jun 2026 | $220.47M USD | -58.3% | -25.3% | 5.5% | |
| LTM Jun 2026 | $174.78M USD | +55.7% | -13.0% | 22.3% | |
| LTM Jun 2026 | $125.3M USD | -91.1% | -55.0% | 1.9% | |
| LTM Mar 2026 | -$7.46M USD | -184.6% | — | 7.5% | |
| LTM Sep 2026 | -$94.49M USD | -265.1% | — | 15.2% | |
| Peer median (excluding AVTR) | — | -13.6% | -9.9% | 21.1% | |
Competitors are the stored peer set for AVTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 7.39B | 7.51B | 6.97B | 6.78B | 6.55B |
| Cost of Revenue | 4.88B | 4.91B | 4.6B | 4.5B | 4.41B |
| Gross Profit | 2.5B | 2.6B | 2.36B | 2.28B | 2.14B |
| Gross Margin | 33.9% | 34.6% | 33.9% | 33.6% | 32.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.53B | 1.47B | 1.51B | 1.64B | 1.6B |
| Operating Expenses | 1.53B | 1.47B | 1.67B | 1.19B | 2.39B |
| Depreciation & Amortization | 379.2M | 405.5M | 402.3M | 405.5M | 410.2M |
| EBITDA | 1.35B | 1.52B | 1.1B | 1.48B | 138.7M |
| EBITDA Margin | 18.3% | 20.3% | 15.8% | 21.8% | 2.1% |
| Operating Income | 972.2M | 1.13B | 696.4M | 1.08B | (246.2M) |
| Operating Margin | 13.2% | 15.0% | 10.0% | 16.0% | -3.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 217.4M | 265.8M | 284.8M | 218.8M | 169.8M |
| Other Income / Expenses | (219.2M) | (279.1M) | (285.9M) | (230.9M) | (195.1M) |
| Income Before Tax | 753M | 851.1M | 410.5M | 853.9M | (441.3M) |
| Pre-Tax Margin | 10.2% | 11.3% | 5.9% | 12.6% | -6.7% |
| Income Tax Expense | 180.4M | 164.6M | 89.4M | 142.4M | 88.9M |
| Net Income | 572.6M | 686.5M | 321.1M | 711.5M | (530.2M) |
| Net Margin | 7.8% | 9.1% | 4.6% | 10.5% | -8.1% |
| EPS (Basic) | 0.86 | 1.02 | 0.48 | 1.05 | (0.78) |
| EPS (Diluted) | 0.85 | 1.01 | 0.47 | 1.04 | (0.78) |
| Weighted Avg Shares | 590.5M | 650.9M | 675.6M | 680.3M | 678M |
| Weighted Avg Shares (Diluted) | 599.6M | 679.4M | 678.4M | 681.9M | 679.3M |
Avantor, Inc.
NYSE:AVTR
Intrinsic Alpha fair value
Locked
Current Price
$15.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.